Long-term outcomes of a phase II trial of neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma of the head and neck (CSCC-HN).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Neil D. Gross, Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Ying Yuan, Diana Bell, Jason M. Johnson, William H. Morrison, David Ira Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Frank Mott, Bita Esmaeli, Eduardo Diaz, Paul Gidley, Ryan Goepfert, Carol M. Lewis, Jennifer Ann Wargo, Randal S. Weber, Jeffrey Myers
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Regeneron Pharmaceuticals
OpenAlex ID: W4281785141